Dr. William Williams, CEO of BriaCell Therapeutics Corp., a company immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer joins eHealth Radio and the Cancer Information and Health News Channels.
Listen to host Eric Michaels & guest Dr. William Williams discuss the following:
Dr. William Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical companies. Dr. Williams served as VP of Exploratory Development at Incyte Corporation from 2005 - 2016. There he facilitated entry of over 20 compounds into the clinic, including ruxolitinib (Jakafi), baricitinib, and epacadostat.
Dr. Williams served as Head of Rheumatology Research at the University of Pennsylvania, ran a major research program in receptor biology, including developing bioactive peptides that mimicked granulocyte-macrophage colony-stimulating factor (GM-CSF), a known stimulant of the immune system. He collaborated with David B. Weiner, Ph.D., a well-known leader in immuno-oncology and vaccine research, in the development of DNA vaccines and was able to bring novel DNA vaccines into the clinic for the treatment of cutaneous T cell lymphoma.
Dr. Williams earned his BSc. in Chemistry and Biotechnology from Massachusetts Institute of Technology and Medical Doctorate from Tufts University School of Medicine. Following his residency at the Boston VA Medical Center, Dr. Williams completed fellowship training in Rheumatology and Cellular Immunology at the University of Missouri. He then joined the molecular immunology laboratory of Mark I. Greene, MD, PhD, FRCP, at the University of Pennsylvania, developed novel methods of bioactive peptide design, and collaborated in the study of the activation of the p185/Human epidermal growth factor receptor 2 (HER2) receptor. HER-2 is a protein which is known to promote the growth of cancer cells. Dr. Williams is the named author at over 130 peer reviewed publications, over 15 patents and numerous Investigational New Drugs (INDs) and NDAs.
Website: www.briacell.com
The First New Ischemic Stroke Treatment in 25 years by DiaMedica Therapeutics
How to Camouflage a Virus: The Latest in Gene Therapy with Genine Winslow
Innovative and Better for your Passsover from Kosher.com: Manischewitz and other great Kosher Brands
Vetster and the Pet Tele-health Medicine Market with Dr. Sarah Machell
How Rise Medical is Making Sexual Wellness Mainstream with CEO Dan Markel
How hypnosis can help you lose weight naturally and quickly
Autumn DNA’s Adam Pivko Is Helping Others Stay Healthy Through Their DNA
This Wall Street exec and former addict left it all to open an mental health center
The Importance of Choosing The Right Plastic Surgeon
Rein in Your Busy Mind to Live More Consciously
No More Surprises! How Provisions of the No Surprises Act Will Impact Employer-Sponsored Health Plans In 2022
The Fertile Life Podcast with Dr. Shahin Ghadir
NasalGuard® Allows You To ‘Breathe Easier’ This Spring to Summer Season
ClariGenZ is finally here - tested and ready!
JScreen.org saves lives – Give a Spit and get Genetic and Cancer Screenings!
Treatment for the American Healthcare Debt Crisis
Helping people think differently about their health, restore hope, and finally feel great
Countifi: AI in Healthcare
How New Parents and Babies Can Get a Good Night’s Sleep
How to Navigate Health Insurance Benefits Whether You’re Employed, Unemployed and Self-Employed
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive